Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-014814
Filing Date
2025-02-05
Accepted
2025-02-05 19:34:41
Documents
1
Period of Report
2025-02-03

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3939
  Complete submission text file 0000950170-25-014814.txt   5385
Mailing Address 202 COUSTEAU PLACE SUITE 105 DAVIS CA 95618
Business Address 202 COUSTEAU PLACE SUITE 105 DAVIS X1 95618 530-756-7077
Arcadia Biosciences, Inc. (Issuer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 0100 Agricultural Production-Crops
(CF Office: 08 Industrial Applications and Services)

Mailing Address 500 CAPITOL MALL, SUITE 2350 SACRAMENTO CA 95814
Business Address
Kawakami Mark (Reporting) CIK: 0002030709 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37383 | Film No.: 25594991